Arcadia

Data-driven healthcare solutions and analytics

Boston, Massachusetts, United States

About Arcadia

Arcadia focuses on improving healthcare outcomes through data-driven solutions in the healthcare sector, particularly in population health management. The company analyzes and manages the health outcomes of groups of people, serving clients such as healthcare providers, insurance companies, and government agencies. Its main product is a data platform that uses big data technology to process and store large volumes of healthcare data, allowing organizations to access and analyze this information effectively. This leads to better decision-making and enhanced patient care. Unlike many competitors, Arcadia offers a comprehensive suite of tools and consulting services that help clients optimize their use of the platform, particularly in areas like STARS HEDIS and risk adjustment accuracy. The goal of Arcadia is to improve efficiency in healthcare delivery, reduce disparities, and achieve better health outcomes for populations.

Boston, MassachusettsHeadquarters
2002Year Founded
$28.7MTotal Funding
DEBTCompany Stage
Consulting, HealthcareIndustries
501-1,000Employees

Benefits

Flexible Work Hours
Unlimited Paid Time Off

Risks

Integration challenges from CareJourney acquisition may disrupt operations.
Departure of former CTO Jonathan Cook could impact Arcadia's innovation.
Intensifying competition in healthcare data analytics threatens Arcadia's market share.

Differentiation

Arcadia integrates CareJourney's market intelligence for comprehensive healthcare insights.
Arcadia's platform offers real-time data analysis for improved healthcare decision-making.
Arcadia's generative AI assistant enhances care team efficiency and reduces burnout.

Upsides

Arcadia's acquisition of CareJourney expands its customer portfolio to nearly 200.
The healthcare data market is projected to triple by 2030, benefiting Arcadia.
Arcadia's AI assistant boosts productivity by reducing data interpretation time.

Funding

Total raised$28.70 M
Latest valuation$147.50 M
StageDEBT
$125
EARLY VC
12/31/2019
$30
$147.50 M